Skip to content
akaturk Academic measurement

Article detail · 2024

Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study

Nephrology

YÖKSİS OpenAlex Open access · bronze SJR Q1 JCR Q3 Citations 6 Percentile 83.1% FWCI 1.65
Year
2024
ISSN
1320-5358
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

BACKGROUND: Primary hyperoxaluria type 1 (PH1) is characterized by increased endogenous oxalate production and deposition as calcium oxalate crystals. The main manifestations are nephrocalcinosis/nephrolithiasis, causing impaired kidney function. We aimed to evaluate the clinical characteristics and overall outcomes of paediatric PH1 patients in Turkey. METHODS: This is a nationwide, multicentre, retrospective study evaluating all available paediatric PH1 patients from 15 different paediatric nephrology centres in Turkey. Detailed patient data was collected which included demographic, clinical and laboratory features. Patients were classified according to their age and characteristics at presentation: patients presenting in the first year of life with nephrocalcinosis/nephrolithiasis (infantile oxalosis, Group 1), cases with recurrent nephrolithiasis diagnosed during childhood (childhood-onset PH1, Group 2), and asymptomatic children diagnosed with family screening (Group 3). RESULTS: Forty-eight patients had a mutation consistent with PH1. The most common mutation was c.971_972delTG (25%). Infantile oxalosis patients had more advanced chronic kidney disease (CKD) or kidney failure necessitating dialysis (76.9% vs. 45.5%). These patients had much worse clinical course and mortality rates seemed to be higher (23.1% vs. 13.6%). Patients with fatal outcomes were the ones with significant comorbidities, especially with cardiovascular involvement. Patients in Group 3 were followed with better outcomes, with no kidney failure or mortality. CONCLUSION: PH1 is not an isolated kidney disease but a systemic disease. Family screening helps to preserve kidney function and prevent systemic complications. Despite all efforts made with traditional treatment methods including transplantation, our results show devastating outcomes or mortality.

Topics

  • Kidney Stones and Urolithiasis Treatments
  • Biomedical Research and Pathophysiology
  • Nephrotoxicity and Medicinal Plants

Primary topic Kidney Stones and Urolithiasis Treatments

Authors

  1. SEVCAN AZİME BAKKALOĞLU EZGÜ
  2. BAHAR BÜYÜKKARAGÖZ GAZİ ÜNİVERSİTESİ
  3. AYŞE SEDA PINARBAŞI
  4. EMRE LEVENTOĞLU
  5. SEHA KAMİL SAYGILI
  6. ELİF ÇOMAK
  7. ZEYNEP NAGEHAN YÜRÜK YILDIRIM
  8. Nurver Akıncı
  9. İSMAİL DURSUN
  10. AYSUN KARABAY BAYAZIT
  11. ASLI KAVAZ TUFAN ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ
  12. SEMA AKMAN
  13. ALEV YILMAZ İSTANBUL ÜNİVERSİTESİ
  14. ZEKİYE AYTÜL NOYAN
  15. AYŞE AĞBAŞ
  16. ERKİN SERDAROĞLU
  17. ALİ DELİBAŞ
  18. AHMET MİDHAT ELMACI NECMETTİN ERBAKAN ÜNİVERSİTESİ
  19. MEHMET TAŞDEMİR
  20. FATİH SÜHEYL EZGÜ
  21. FATMA LALE SEVER